Trials / Sponsors / Dantari, Inc.
Dantari, Inc.
Industry · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Dose-escalation Study of the Safety and Pharmacology of DAN-222 in Subjects With Metastatic Breast Cancer HER2-negative Metastatic Breast Cancer | Phase 1 | 2022-02-02 |